Analysis of differentially expressed genes by Mirex 'persistent organic pollutant' in HepG2 cells

Toxicology and Environmental Health Sciences

Volumn 3, Issue 4, 2011, Pages 245-253

  Choi, Han Seam ^a   Song, Mee ^a   Song, Mi Kyung ^a   Kim, Youn Jung ^b   Ryu, Jae Chun ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Gene ontology (GO); Microarray; Mirex; Persistent Organic Pollutants (POPs)

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10; MESSENGER RNA; MIREX; PLASMINOGEN; PLASMINOGEN ACTIVATOR; UROKINASE;

ADIPOSE TISSUE; ARTICLE; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER TOXICITY; MARKER GENE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; POLLUTANT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE;

EID: 84873272507     PISSN: 20059752     EISSN: 22337784     Source Type: Journal    
DOI: 10.1007/s13530-011-0105-2     Document Type: Article

References (34)

1. Fisher, B. E. Most unwanted. Environ. Health. Perspect. 107, A18-23 (1999).
2. Yarbrough, J. D. et al. Tissue disposition, metabolism, and excretion of cis- and trans-5, 10-dihydrogen mirex. Drug. Metab. Dispos. 11, 611-614 (1983).
3. Baetcke, K. P., Cain, J. D. & Poe, W. E. Mirex and DDT residues in wildlife and miscellaneous samples in Mississippi-1970. Pestic. Monit. J. 6, 14-22 (1972).
4. Wolfe, J. L. & Norment, B. R. Accumulation of mirex residues in selected organisms after aerial treatment. Mississippi. 1971-1972. Pestic. Monit. J. 7, 112-116 (1973).
5. Hallet, D. J., Norstrom, R. J., Onuska, F. I., Comba, M. E. & Sampson, R. Mass spectral confirmation and analysis by the Hall detector of mirex and photomirex in herring gulls from Lake Ontario. J. Agric. Food. Chem. 24, 1189-1193 (1976).
6. Leatherland, J. F. & Sonstegard, R. A. Effect of dietary mirex and PCBs on calcium and magnesium metabolism in rainbow trout, Salmo gairdneri and Coho salmon, Oncorhynchus kisutch; a comparison with Great Lakes Coho salmon. Comp. Biochem. Physiol. 69, 345-351 (1981).
7. LeBel, G. L. & Williams, D. T. Determination of halogenated contaminants in human adipose tissue. J. Assoc. Off. Anal. Chem. 69, 451-458 (1986).
8. Bustnes, J. O. et al. Organochlorines in antarctic and arctic avian top predators: a comparison between the South Polar Skua and two species of northern hemisphere gulls. Environ. Sci. Technol. 40, 2826-2831 (2006).
9. Karen, L. et al. 17beta-estradiol is a hormonal regulator of mirex tumor promotion sensitivity in mice. Toxicol. Sci. 69, 42-48 (2002).
10. Kutz, F. W. et al. The human body burden of mirex in the southeastern United States. J. Toxicol. Environ. Health. 15, 385-394 (1985).
11. van Oostdam, J. C. et al. Circumpolar maternal blood contaminant survey, 1994-1997 organochlorine compounds. Sci. Total. Environ. 330, 55-70 (2004).
12. Deutch, B., Pederson, H. S. & Hansen, J. C. Dietary composition in Greenland 2000, plasma fatty acids and persistent organic pollutants. Sci. Total. Environ. 331, 177-188 (2004).
13. Chakraborty, T. et al. Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression. Life. Sci. 81, 489-499 (2007).
14. Lynch, D. et al. Mouse skin models for carcinogenic hazard identification: utilities and challenges. Toxicol. Pathol. 35, 853-864 (2007).
15. IARC. Mirex. In Some Organochlorine Pesticides. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, vol. 5. Lyon, France: International Agency for Research on Cancer. pp. 203-210 (1974).
16. IARC. Mirex. In Some Halogenated Hydrocarbons. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, vol. 20. Lyon, France: International Agency for Research on Cancer. pp. 283-301 (1979).
17. Song, M., Kim, Y. J. & Ryu, J. C. Identification of genes induced by benzophenone-2 in human thyroid follicular FTC-238 cells. Mol. Cell. Toxicol. 7, 103-111 (2011).
18. Sarma, S. N., Kim, Y. J. & Ryu, J. C. Gene expression profiles of human promyelocytic leukemia cell lines exposed to volatile organic compounds. Toxicology271, 122-130 (2010).
19. Song, M. K., Kim, Y. J., Song, M. & Ryu, J. C. Gene expression analysis identifies potential biomarkers of phenanthrene in human hepatocytes (HepG2). Toxicol. Environ. Health. Sci. 3, 30-38 (2011).
20. Northup, P. G. et al. Hypercoagulation and thrombophilia in liver disease. J. Thromb. Haemost. 6, 2-9 (2007).
21. Levy, G. A., MacPhee, P. J., Fung, L. S. Fisher, M. M. & Rappaport, A. M. The effect of mouse hepatitis virus infection on the microcirculation of the liver. Hepatology3, 964-973 (1983).
22. MacPhee, P. J., Schmidt, E. E., Keown, P. A. & Groom, A. C. Microcirculatory changes in livers of mice infected with murine hepatitis virus. Evidence from microcorrosion casts and measurements of red cell velocity. Microvasc. Res. 36, 140-149 (1988).
23. Wanless, I. R. et al. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology21, 1238-1247 (1995).
24. Wanless, I. R., Liu, J. J. & Butany, J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology21, 1232-1237 (1995).
25. Wright, M. et al. Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection. Gut52, 1206-1210 (2003).
26. Poujol-Robert, A., Boelle, P. Y., Poupon, R. & Robert, A. Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis C. Hepatology39, 1174-1175 (2004).
27. Papatheodoridis, G. V. et al. Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. Gut52, 404-409 (2003).
28. Bezerra, J. A. et al. Plasminogen activators direct reorganization of the liver lobule after acute injury. Am. J. Pathol. 158, 921-929 (2001).
29. Shimizu, M. et al. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis. Hepatology33, 569-576 (2001).
30. Soultati, A. & Dourakis, S. P. Coagulation disorders in liver diseases. Haema9, 31-44 (2006).
31. Garred, P. Mannose-binding lectin genetics: from A to Z. Biochem. Soc. Trans. 36, 1461-1466 (2007).
32. Takahashi, K. Lessons learned from murine models of mannose-binding lectin deficiency. Biochem. Soc. Trans. 36, 1487-1490 (2008).
33. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65, 55-63 (1983).
34. Park, H. W. et al. Gene expression patterns of environmental chemicals in human cell lines using Haz-Chem human array. BioChip J. 3, 65-70 (2009).